Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compounds, formulations, and methods for treating or preventing inflammatory skin disorders

A skin disease, inflammatory technology, applied in the field of compounds for the treatment or prevention of inflammatory skin diseases, can solve problems such as inability to treat diseases

Inactive Publication Date: 2009-05-06
SANSROSA PHARMA DEV
View PDF8 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In patients with nasal hyperplasia, surgical reduction improves the patient's appearance but does not treat the disease itself

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
  • Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
  • Compounds, formulations, and methods for treating or preventing inflammatory skin disorders

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0110] 1.7.1 Example 1: (5-bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine Synthesis

[0111] To a stirred solution of 6-amino-5-bromoquinoxaline hydrogen bromide (10 g) in distilled water (150 mL) was added thiophosgene (3 mL). The solution was stirred at room temperature for 2 h, and the resulting precipitate was collected by filtration, rinsed with water, and dried to give 5-bromo-6-isothiocyanato-quinoxaline.

[0112] 5-Bromo-6-isothiocyanato-quinoxaline (3.5 g) was directly dissolved in benzene (400 mL), and added dropwise to well-stirred ethylenediamine (15 g ) in the solution. In about two hours, an oil layer separated as the lower layer. The upper benzene layer was discarded, and the oil layer was washed with diethyl ether, and then dissolved in methanol (500 mL). The methanol solution was refluxed until evolution of hydrogen sulfide ceased. The methanol solution was concentrated under vacuum to a volume of about 100 mL, a yellow solid precipitated....

Embodiment 2

[0114] Aqueous aqueous topical formulations of the present invention include (5-bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine-L-tartrate (brimonide tartrate) (0.15wt.%); as a preservative (0.005%) (stabilized chlorine dioxide); and inert components: boric acid, calcium chloride, magnesium chloride, potassium chloride, pure water, sodium borate, sodium carboxymethylcellulose, sodium chloride, and with hydrochloric acid and / or sodium hydroxide to adjust the pH value to 5.6-6.6. The osmolality is 250-350mOsmol / kg.

Embodiment 3

[0116] Aqueous aqueous topical formulations of the present invention include (5-bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine-L-tartrate (brimonide tartrate) (0.15wt%); benzylamine chloride as a preservative; and inert components: boric acid, calcium chloride, magnesium chloride, potassium chloride, purified water, sodium borate, sodium carboxymethylcellulose, Sodium chloride, and adjust the pH value to 5.6-6.6 with hydrochloric acid and / or sodium hydroxide. The osmolality is 250-350mOsmol / kg.

[0117] 1.7.4 Example 4

[0118] Possible cream topical formulations of the invention are described in the table below.

[0119] Possible Cream Topical Formulations of the Invention (Hydrophilic Ointment USP)

[0120] components weight percentage Brimonidine tartrate 0.15％ stearic acid 7％ stearyl alcohol 5％ cetyl alcohol 2％ glycerin 10％ sodium lauryl sulfate 1％ Propylparaben 0.05％ Methylparaben 0.25％ D...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

In methods, compounds, and topical formulations for treatment of rosacea incorporating compounds represented by the formulas below: wherein each of R1, R2, and R3 is independently hydrogen, hologen, alkyl, or alkoxy; each of R4 and R5 is independently hydrogen, alkyl, or alkoxy; and each of R6 and R7 is independently hydrogen, nitro, alkyl, or alkoxy; wherein each of A1, A3, and A4 is independently hydrogen or alkyl; and A2 is independently hydrogen or hydroxy; and wherein each of B1, B2, and B3 is independently hydrogen, hydroxy, or alkoxy; and each of B4 and B5 is independently hydrogen or alkyl, applying such compounds topically as sprays, mists, aerosols, solutions, lotions, gels, creams, ointments, pastes, unguents, emulsions, and suspensions to treat rosacea and its symptoms.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to US Patent Application Serial No. 60 / 574,142, filed May 25, 2004, the contents of which are incorporated herein by reference. This application is also a division of U.S. Patent Application No. 10 / 853,585, filed May 25, 2004, which in turn claims priority from U.S. Patent Application No. 60 / 473,611, filed May 27, 2003, the contents of which are incorporated in Here for reference. technical field [0003] The present invention relates to compounds and methods for the treatment or prevention of inflammatory skin diseases (inflammatory conditions of the skin). The compounds and methods provided herein are particularly useful for treating or preventing inflammatory skin diseases and symptoms associated therewith. Background technique [0004] Many people are affected by inflammatory skin diseases that cause unsightly and painful rashes, acne, persistent red blood vessels, and acne-like r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/498A61K31/4164A61K31/137
CPCA61K31/498A61K31/4164A61K31/137A61K9/0014A61K9/06A61K31/4174A61K45/06A61K2300/00A61P17/00A61P17/02A61P17/10A61P29/00
Inventor 杰克·A·德约文托马斯·M·罗西
Owner SANSROSA PHARMA DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com